Clinical trials
Rabies trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Unknown status | 5 |
| Not yet recruiting | 3 |
| Active, not recruiting | 2 |
| Recruiting | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Vaccines | 4 |
| Synermore Biologics (Suzhou) Co., Ltd. | 4 |
| Ningbo Rongan Biological Pharmaceutical Co., Ltd. | 3 |
| Ab&B Bio-tech Co., Ltd.JS | 2 |
| Changchun BCHT Biotechnology Co. | 2 |
| Jiangsu Province Centers for Disease Control and Prevention | 2 |
| Sinovac Biotech Co., Ltd | 2 |
| Changchun Zhuoyi Biological Co., Ltd | 1 |
| China National Biotec Group Company Limited | 1 |
| Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Rabies | 25 |
| COVID-19 | 1 |
| Communicable Diseases | 1 |
| Mononegavirales Infections | 1 |
| RNA Virus Infections | 1 |
| Rhabdoviridae Infections | 1 |
| Virus Diseases | 1 |
Trials
Showing 51 to 25 of 25. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.